Inova acquires IN-PART, matchmaking platform for academia-industry collaboration
Lyon, France, 8 February 2022 – Inova announces the acquisition of IN-PART, a digital matchmaking platform dedicated to academia-industry collaboration. Along with the recent acquisition of Labiotech, this move consolidates Inova’s position as a leader and pioneer in the digitalization of the biopharma partnering space, supported by the €60 million investment from global private equity firm Carlyle (NASDAQ: CG) and reaffirmation of a strong commitment by NextStage AM, in 2021.
Inova supports more than 160 global clients, including many of the world’s largest pharmaceutical companies, and is at the forefront of digital transformation in biopharma collaborations. Inova’s flagship product, Inova Partnering Platform, serves as a collaborative tool used to manage all potential partnerships related to outsourced innovation to pharma and biotechs, enabling customers to source leads, execute transactions, and manage alliances and virtual events.
IN-PART develops curated digital solutions that drive impact from research by streamlining relationships between industry professionals and the world of academic institutions. IN-PART's matchmaking platform, Connect, is used by 250+ universities and research institutes to find new partners for commercialization across more than 6,000 companies. The company’s bespoke scouting platform, Discover, is used by sector leaders to engage academics, TTOs, and research service departments in more than 1,500 institutes with specific R&D challenges or requirements.
This acquisition is a major step forward for academia-industry partnering. While IN-PART will continue to service and expand its platforms for all research sectors, by joining forces with Inova, the company will gain access to Inova’s software infrastructure, as well as their market-leading teams in product and marketing. In turn, Inova clients will benefit from access to IN-PART search and discovery platforms, as well as leveraging best practice in matchmaking technology. By creating a stronger, more connected research ecosystem, this acquisition will ensure academic breakthroughs have an even greater impact on society.
Inova is a cloud-based solution aimed at helping life science companies locate and manage their biopharma opportunities more efficiently. It offers a platform for partnering events, secure licensing and collaboration opportunities, and successful deal making and alliance management. Inova has over 125 employees and is headquartered in Lyon, France, with offices in New York, Denver, and Tokyo. Further information is available at inova.io. Follow Inova on LinkedIn and Twitter.
IN-PART provides digital matchmaking platforms for teams in academia and industry striving for greater positive impact through collaboration. Launched in 2014, IN-PART has offices in Sheffield and London, with a team of 50 employees, primarily from STEM backgrounds, who manage and curate their platforms. Further information is available at in-part.com. Follow IN-PART on LinkedIn and Twitter.
Tel: +33 (0) 6 24 86 81 69
+44 (0) 7474 887 855
Virtual partnering event launched to accelerate partnerships in the life sciences industry to fight against COVID-19
COVID-19 Virtual Partnering is a unique and free-to-attend virtual event taking place on 20 April...Read more
Inova, software editor of a CRM dedicated to pharmaceutical companies, has followed software trends,...Read more